Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.18 USD | -32.83% |
|
-10.03% | +157.35% |
Jun. 10 | Lipocine Inc. Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late-Breaking Session at EASL Congress 2024 | CI |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 11.28 | 12.79 | 19.04 |
Spread/Res. | -36.35% | -43.86% | -62.29% |
Spread/Supp. | +1.27% | +50.84% | +53.42% |
Support | 7.090 | 4.760 | 4.680 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LPCN Stock
- Charts Lipocine Inc.